| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |